Whalesbook
The Underperformance Riddle
Indian equity markets concluded 2025 with a muted 8-10% advance, extending the Nifty 50's streak of positive annual returns to ten years, yet this performance paled against global peers. Major markets like Japan and South Korea posted gains exceeding 20%, while the MSCI Emerging Markets Index also significantly outpaced Indian benchmarks, delivering a notable 34% return in 2025. This divergence occurred despite substantial domestic inflows and a more stable macroeconomic backdrop than in previous years. Factors contributing to this underperformance included persistently elevated equity valuations, a deceleration in corporate earnings growth, and significant foreign portfolio investor (FPI) outflows throughout much of the year. The year saw the Nifty 50 advance by approximately 10.7%, a performance that, while positive, was considerably more subdued than in preceding periods.
AI's Double-Edged Sword: Sectoral Shifts and Valuations
The Artificial Intelligence (AI) revolution continued to be a dominant theme, with global investment in the sector surging. Indian firms demonstrated high confidence and significant investment in AI, planning substantial spending on software, infrastructure, and talent, exceeding global averages. The IT sector, a traditional engine of Indian growth, is actively integrating AI capabilities, with projections indicating a strong recovery in AI-related expenditures for 2026. However, the broader market narrative in 2025 was shaped by a narrower market rebound, where large-cap stocks, particularly those benefiting from AI tailwinds or robust earnings, largely drove gains, while many mid- and small-cap companies struggled. This concentration risk highlights a potential disconnect between headline market strength and underlying business performance across segments.
The Small-Cap Gamble: Entry Points vs. Structural Risks
Amidst the market's divergence, a key recommendation emerging from financial commentary is to increase allocation towards small- and mid-cap stocks, leveraging recent sharp corrections. The Nifty SmallCap index, which had previously delivered exceptional returns, experienced its worst year since 2022, declining by approximately 7-9% in 2025. Analysts point to these declines as creating potentially attractive entry points for long-term investors. However, this strategy is not without significant risks. Valuations for mid- and small-cap stocks remain stretched, with forward P/E multiples of 29.2x and 25.1x, respectively, well above their long-term averages. Compounding these concerns are widespread earnings misses in the small-cap segment during the second half of FY26, where nearly 40% of companies failed to meet expectations, leading to a 5% year-on-year decline in earnings for the segment.
Regulatory Crosscurrents and Global Macro
Several significant regulatory and trade developments are shaping the investment outlook. The signing of the landmark India-EU Free Trade Agreement (FTA) aims to enhance trade and supply chains, promising tariff reductions, particularly beneficial for the pharmaceutical sector. Similarly, the recent India-US trade deal, which saw a reduction in tariffs to 18% on many Indian exports, aims to reset economic ties, with potential positive impacts on export-oriented sectors. The Union Budget 2026 introduced measures such as a significant capex push, support for semiconductor manufacturing, and initiatives in biopharma and railways, signaling a focus on infrastructure and domestic growth. Globally, a more accommodative financial environment is anticipated, with expectations of easing interest rates and a potentially softer US dollar supporting emerging markets. However, headwinds from trade policy uncertainty and the implementation of measures like the EU's Carbon Border Adjustment Mechanism (CBAM) present ongoing challenges for Indian exporters.
The Bear Case: Valuation Traps and Earnings Woes
The narrative advocating for a greater allocation to small and mid-caps overlooks the structural challenges that have plagued these segments. The elevated valuations, coupled with consistent earnings disappointments, suggest that the perceived 'entry points' may represent value traps rather than true opportunities for sustainable growth. The broad market correction in 2025, where nearly 73% of Nifty 500 stocks remained more than 10% below their record highs, underscores systemic issues rather than isolated stock-specific problems. Concentration risk in sector-specific funds, a concern highlighted by analysts, is also amplified in the small-cap universe, where a downturn in a particular industry can disproportionately impact investors. The historical outperformance of these segments often relies on robust earnings growth, which has been notably absent in recent quarters for many small-cap companies.
The Year Ahead: Divergent Paths
Looking towards 2026, the outlook for Indian equities is cautiously optimistic, with expectations of better performance driven by improving earnings, steady economic growth, and more reasonable valuations compared to the 2025 lag. Analysts suggest that the market performance will likely be bifurcated, rewarding selective stock picking rather than passive index investing. While global trends in AI investment and supportive macro policies provide a constructive backdrop, the inherent risks of stretched valuations in smaller caps and the potential for regulatory hurdles necessitate a balanced approach. The market's path will hinge on whether the narrative of structural growth in India can translate into consistent earnings recovery across all market capitalizations, or if the current volatility and valuation concerns will continue to suppress broader market participation.